CoChat

Herpes simplex virus type 2: a key role in HIV incidence

Glynn, Judith R, Biraro, Samuel, Weiss, Helen A · 2009 · AIDS
Cited by 85

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Many epidemiological studies have found a strong association between HSV-2 infection and HIV infection, including longitudinal studies in which it was known that the HSV-2 infection preceded the HIV infection [1]. However, two recent trials of suppressive therapy of HSV-2 with acyclovir (400 mg b.i.d) showed no reduction in HIV incidence [2,3]. Although this may simply reflect the difficulty of adequately suppressing HSV-2 reactivations with the drug regimen used, the results have led some to challenge the importance of HSV-2 infection as a risk factor for HIV [4]. In this issue, Tobian et al.[5] use data from the Rakai male circumcision trial to assess the effect of prevalent and incident HSV-2 infection on HIV incidence. They found that prevalent HSV-2 infection increased HIV incidence three-fold, and that men who acquired HSV-2 during follow-up had a six-fold risk of HIV incidence, in analyses adjusted for sexual behaviour. These results are very similar to those found in a systematic review [1]. This included cohort and nested case–control studies up to 2004, and identified 18 that were adjusted for age and sexual behaviour. We have re-run the meta-analysis including more recent studies that fit the same criteria (Fig. 1). Six additional studies, as well as that by Tobian et al.[5], are included: one in men from the circumcision trial in South Africa [6]; two in women in the general population, in Uganda and Zimbabwe [7]; two in female sex workers in Kenya [8] and Tanzania [9]; and one in men who have sex with men (MSM) in the US [10]. Summary estimates of the relative risk (RR) show a strong and consistent association of prevalent HSV-2 and incident HIV after adjusting for age and measures of sexual behaviour [RRwomen = 3.4, 95% confidence interval (CI) 2.4–4.8; RRmen = 2.8, 2.1–3.7; RRsex workers = 1.5, 0.75–3.0; RRMSM = 1.6, 1.2–2.0). In addition, a cohort study in Uganda found an adjusted rate ratio of 8.7 (1.1–67.2) for men and women combined [11].Fig. 1: Meta-analysis of the effects of prevalent HSV-2 on incident HIV infection. Studies from the previous meta-analysis are shown in normal type (see [1] for details). Additional studies are shown in bold. For each study the relative risk and 95% CI are shown. The size of the squares reflects the weight of the study. The summary relative risks are shown as diamonds.The observational epidemiological evidence is strong, but Tobian et al.[5] question whether the association between HSV-2 and HIV is causal. Whereas confounding by sexual risk behaviour is likely in these studies, the effect persists after adjusting for sexual behaviour, and in their analysis this adjustment makes very little difference. In fact the association may be underestimated: some studies adjust for genital ulceration, which lies on the causal pathway between HSV-2 and HIV infection; and tests for HSV-2 lack specificity [12], which would also tend to bias the RR towards one. The association between recent HSV-2 infection and HIV incidence is generally stronger than the association with prevalent HSV-2 infection [1,6–8,10]. This is biologically plausible as clinical and subclinical reactivations are most common shortly after HSV-2 infection [13]. However, results are difficult to interpret since, unless repeat testing is very frequent, most seroconversions for both infections occur within the same follow-up interval. It is therefore impossible to know which came first and therefore to distinguish HIV-2 infection increasing susceptibility to HIV from coinfections from the same source. In the study by Tobian et al., HSV-2 preceded HIV in three individuals, but the relative timing was unknown in nine. Some studies include all who seroconvert, even when the timing is unknown, which is likely to overestimate the association. Others exclude those for whom the timing is unknown, but this is also biased, since it excludes some who do acquire HIV, and none who do not, so is likely to underestimate the association. In Zimbabwe and Uganda, where the proportion excluded was small, recent HSV-2 infection was associated with a 4–8-fold increase in HIV incidence [7]. That prior HSV-2 infection increases susceptibility to HIV is thus well supported epidemiologically, and is also biologically plausible. However, the effect of HSV-2 on increasing susceptibility to HIV is only part of the story of their interaction, as genital ulceration and HSV-2 infection also increase HIV plasma load, HIV shedding, and hence transmissibility [14–16], and HIV infection increases the risk of acquisition of HSV-2, and the frequency and severity of reactivations [16]. Randomized controlled trials of HSV suppressive therapy with valacyclovir or high-dose acyclovir (800 mg b.i.d) have shown a significant reduction in genital and plasma HIV-1 RNA levels [17–20], although trials using lower-dose acyclovir (400 mg b.i.d) have tended to find less of an effect [21–23]. Recently announced results from the Partners in Prevention

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/qad.0b013e32832e15e8

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 85

Metadata

Authors
Glynn, J. R., Biraro, S., & Weiss, H. A.
Venue
AIDS
Published
2009-07-31
Volume
23
Issue
12
Pages
1595-1598
ISSN
0269-9370 (ISSN-L)
OpenAlex
W1978317163
Cited by
85
References
2
FWCI
6.37
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.